marijuana stocks news

Chairman of the Board Ambassador Ned L. Siegel Invests in Medbox

Medbox, Inc. (OTCQB:MDBX) (www.medbox.com), a leading dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry, announced today that Ambassador Ned L. Siegel (Ret.), Chairman of its Board of Directors, has invested $50,000 in Medbox through the issuance of a convertible loan.

Ambassador Siegel stated, “I believe that Medbox is in a unique position in the cannabis industry to advise investors and entrepreneurs as to how to obtain the required licenses to operate, and subsequently how to manage their businesses with the highest levels of safety, security, profitability and best practices. My investment in the company reflects my confidence that Medbox can build on its market positioning to generate sustainable and profitable revenue growth.”

About Medbox, Inc.
Medbox, Inc. (“MDBX” or the “Company”) is the leading dispensary infrastructure and licensing specialist, patented technology provider, and partner to the cannabis industry. Headquartered in Los Angeles, CA, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers its patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical line of vaporizer products. Medbox, through its newly established subsidiaries, is also developing ancillary services tailored to the alternative medicine industry, including real estate acquisitions and subsequent lease programs to alternative medicine dispensaries and cultivation centers, and alternative medicine dispensary and cultivation management services.

Forward-Looking Statements
The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward looking statement was made.

Contact Information

Investor Relations:
Stephen Hart
Hayden IR
917-658-7878
hart@haydenir.com

Medbox:
For more information on Medbox, please call (800) 762-1452.

Contact:
Hayden IR
Investor Relations:
Stephen Hart, 917-658-7878
hart@haydenir.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published.

You May Also Like

$MJNA Products on Yahoo Finance

Medical Marijuana, Inc.’s HempMeds CBD Oil Products Featured by Yahoo Finance The…

$MDBX Has Comments on Recent 8-K Filing

Medbox Comments on Recent 8-K Filing Company adds context and clarifies matters…

Cannabis Science, Inc. (CBIS) Announces the Nearing Completion of a Novel Patentable Formulary Cannabinoid Medication

Cannabis Science, Inc. Announces the Nearing Completion of a Novel Patentable Formulary…

$MJNA Announces Publication of Its Global PCT Patent

Medical Marijuana, Inc’s Portfolio Investment Company Kannalife Sciences Announces Publication of Its…